Pfizer suffered a setback in Britain on Thursday when the Court of Appeal in London ruled against it in a patent case over the use of its $5 billion-a-year drug Lyrica for pain relief.
Pfizer said it was disappointed by the decision and would seek a further appeal.
Source: Reuters
Filed Under: Drug Discovery
